<SEC-DOCUMENT>0001564590-19-026112-index.html : 20190725 <SEC-HEADER>0001564590-19-026112.hdr.sgml : 20190725 <ACCEPTANCE-DATETIME>20190725160219 ACCESSION NUMBER: 0001564590-19-026112 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20190725 DATE AS OF CHANGE: 20190725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-232817 FILM NUMBER: 19974445 BUSINESS ADDRESS: STREET 1: 520 PIKE STREET STREET 2: SUITE 2250 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 520 PIKE STREET STREET 2: SUITE 2250 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20080821 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 </SEC-HEADER> <DOCUMENT> <TYPE>S-1 <SEQUENCE>1 <FILENAME>achv-s1.htm <DESCRIPTION>S-1 <TEXT> Document 1 - file: achv-s1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>achv-ex51_106.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: achv-ex51_106.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>achv-ex231_107.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: achv-ex231_107.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>gt2vvegzq5rf000002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: gt2vvegzq5rf000002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>gfac2bmokzpz000001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: gfac2bmokzpz000001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>gt2vvegzq5rf000001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: gt2vvegzq5rf000001.jpg
</DOCUMENT> </SEC-DOCUMENT>